Sign up to access historical data
Similar companies
Company | Est. Transaction Value | |
---|---|---|
Gilead SciencesGILD |
-$8,000 | |
Anavex Life SciencesAVXL |
-$8,000 | |
AmgenAMGN |
-$500 | |
Editas MedicineEDIT |
-$8,000 | |
Alnylam PharmaceuticalsALNY |
-$8,000 |
Trades by US Politicians
Politician | Filing Date | Type | Size |
---|---|---|---|
Joshua Gottheimer Democrat | Apr 15, 2024 | Buy | $1K - $15K |
Joshua Gottheimer Democrat | Mar 14, 2024 | Sell | $1K - $15K |
Joshua Gottheimer Democrat | Dec 7, 2023 | Buy | $1K - $15K |
Joshua Gottheimer Democrat | Dec 6, 2023 | Buy | $1K - $15K |
Joshua Gottheimer Democrat | Dec 5, 2023 | Buy | $1K - $15K |
Who is the latest politician to buy or sell BioNTech shares?
Joshua Gottheimer purchased BioNTech shares most recently on April 15, 2024.
Which politician has bought the most BNTX stock in the last two years?
Joshua Gottheimer has bought the most BNTX stock in the last 2 years, with an estimated value of $32,000.
Which politician has sold the most BNTX stock over the last two years?
Joshua Gottheimer has sold the most BNTX stock in the last 2 years, with an estimated value of $8,000.
What is the total value of politicians trading BNTX stock in the last 2 years?
According to our estimates, the net value of trades by US politicians for BioNTech in the last 2 years is positive, amounting to $24,000. This indicates that US politicians have reasons to believe that the stock is going to go up.
How do insider transactions over the last 2 years reflect on BioNTech's market confidence?
Over the last 2 years, insider transactions for BioNTech have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.